The Pharma Data

AUGUST 15, 2021

2021 Apr 8:2021.04.08.438884. Melody Swartz, Jeffrey Hubbell and colleagues had previously developed a vaccine delivery tool called polymersomes – self-assembling, spherical nanoparticles that can encapsulate antigens and adjuvants (helper molecules that boost the immune response) and then release them inside immune cells.

Vaccine 52

Vaccine Virus Immune Response Clinical Trials 52

The Pharma Data

JANUARY 21, 2021

21, 2021 — U.S. President Joe Biden has promised to re-energize the nation’s response to COVID-19, but one of his top pandemic advisors says that effort could be hamstrung by both the virus and the failings of the previous administration. © 2021 HealthDay. Posted: January 2021. THURSDAY, Jan. Source link.

Vaccine 52

Vaccine Virus RNA Research 52

The Pharma Data

AUGUST 27, 2020

These antibodies were higher than those seen in people who had recovered from the virus. There is hope that Moderna’s vaccine could be available by early 2021. . The researchers saw the participants produce neutralising antibodies, which they believe is needed to help build immunity to COVID-19. Conor Kavanagh. Source link.

Vaccine 90

Vaccine Immune Response Clinical Trials Virus 90

SCIENMAG: Medicine & Health

JULY 13, 2023

As a result of the COVID-19 pandemic, respiratory syncytial virus (RSV) surges in young children occurred outside the usual November to March season, when immune-based prophylactic is available to protect children at high risk for severe illness.

Hospitals 70

Hospitals Virus 70

The Pharma Data

DECEMBER 21, 2020

Kaiser Permanente has announced that it will extend its waiver for most member out-of-pocket costs for inpatient and outpatient services related to the treatment of COVID-19 through at least March 31, 2021 , or as long as the ongoing public health emergency lasts. OAKLAND, Calif. ,

Virus 52

Virus Clinical Research Treatment Disease 52

The Pharma Data

JANUARY 6, 2021

7, 2021 /PRNewswire/ — OyaGen, Inc. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.’ ’ (2021) Viruses 13:52 [link]. ROCHESTER, N.Y. , Bennett et al., About OYA1. OYA1 (a.k.a.

Virus 40

Virus Clinical Trials Government Laboratories 40

The Pharma Data

MARCH 2, 2021

(Nasdaq: GILD) today announced the upcoming presentation of new data from the company’s HIV, hepatitis C virus (HCV), and COVID-19 research and development programs at the 28th Conference on Retroviruses and Opportunistic Infections ( virtual CROI 2021) taking place from March 6-10. HIV Research. COVID-19 Research.

Virus 40

Virus Treatment Science Trials 40

The Pharma Data

MARCH 8, 2021

The companies today reported findings on one secondary objective from the Phase 2a study, showing a reduction in time (days) to negativity of infectious virus isolation in nasopharyngeal swabs from participants with symptomatic SARS-CoV-2 infection, as determined by isolation in Vero cell line culture. About Molnupiravir.

Trials 69

Trials Virus RNA Research Laboratories 69

The Pharma Data

DECEMBER 28, 2020

New York City issued a competitive request for proposal (RFP) for the 2021 school year, and we are excited to have been selected from the many labs who replied. We look forward to continuing to do our part to help keep schools safe through the remainder of the 2021 school year,” added Perthuis. TEMPLE CITY, Calif.,

Virus 52

Virus Hospitals Marketing International 52

The Pharma Data

JANUARY 11, 2021

11, 2021 — After a long delay, World Health Organization experts are expected to arrive in China on Thursday to investigate the origins of the COVID-19 pandemic, according to officials. At the same time, state-owned media have played up fringe theories that suggest the virus could have originated elsewhere. © 2021 HealthDay. .”

Virus 52

Virus Government Marketing Research 52

Broad Institute

JUNE 10, 2024

With this goal in mind, Liu’s team is now working on combining eePASSIGE with delivery systems such as engineered virus-like particles (eVLPs) that may overcome hurdles that have traditionally limited therapeutic delivery of gene editors in the body.

DNA 144

DNA Engineering Therapies Disease 144

The Pharma Data

JANUARY 26, 2021

26, 2021 — The first known U.S. “We know that even as we work hard to defeat COVID-19, the virus continues to evolve as all viruses do,” Minnesota Health Commissioner Jan Malcolm said in a statement. © 2021 HealthDay. Posted: January 2021. Professional. Brazilian Coronavirus Variant Found in Minnesota.

Virus 52

Virus Disease Research 52

The Pharma Data

JANUARY 21, 2021

Researchers randomized patients to either 4,200 mg of IV-administered bamlanivimab or placebo and saw that after eight weeks of participant follow-up, the 965 participants who tested negative for the virus at baseline saw a 57 percent lower frequency of symptomatic COVID-19 in the drug arm compared to the placebo arm.

Nurses 52

Nurses Research Laboratories Laboratories Virus 52

The Pharma Data

JANUARY 6, 2021

Process development and quality control will begin in 2021, and full manufacturing capabilities at the 88,000-square-foot facility will be available in 2023. In addition to its lead program, which began Phase I testing in 2020, the company expects to nominate three clinical candidates in 2021.

Virus 52

Virus FDA Approval Clinical Trials Trials 52

The Pharma Data

SEPTEMBER 5, 2021

Under the agreement, AstraZeneca commits to deliver 60 million doses of the vaccine by the end of the third quarter 2021, 75 million by the end of the fourth quarter 2021 and 65 million by the end of the first quarter 2022. Legal proceedings by the European Commission against AstraZeneca were initiated in Brussels on 21 April 2021.

Vaccine 52

Vaccine Virus Clinical Trials Trials 52

The Pharma Data

JANUARY 11, 2021

11, 2021 — As the rollout of the COVID-19 vaccines continues, scores of questions are emerging. The COVID-19 vaccines work by teaching the immune system to protect against the virus, experts said. Neither of the two vaccines approved in the United States — made by Pfizer-BioNTech and Moderna — contains the live virus.

Vaccine 52

Vaccine Virus DNA Doctors 52

The Pharma Data

FEBRUARY 1, 2021

1, 2021 – The National Institutes of Health has launched a new database to collect information and biospecimens from people who have experienced neurological problems associated with severe acute respiratory syndrome coronavirus 2 infection. © 2021 HealthDay. . © 2021 HealthDay. Posted: February 2021. Professional.

Virus 52

Virus Treatment Research 52

The Pharma Data

JANUARY 6, 2021

6, 2021 — The head of the World Health Organization said Tuesday that he is “disappointed” that Chinese officials have not given permission for experts to come to China to track the origins of COVID-19. © 2021 HealthDay. Posted: January 2021. Professional. WEDNESDAY, Jan. AP News Article. All rights reserved.

Virus 52

Virus Government International Research 52

The Pharma Data

JANUARY 13, 2021

13, 2021 — People flying to the United States will soon need to show proof of a negative COVID-19 test result, the U.S. It is likely that the recently identified version of the virus from the United Kingdom is “probably in every state or most states. © 2021 HealthDay. Posted: January 2021. WEDNESDAY, Jan.

Virus 52

Virus Disease 52

The Pharma Data

SEPTEMBER 8, 2021

Roche to acquire the TIB Molbiol Group with the expectation to close in fourth quarter of 2021. Closing of the transaction is subject to customary conditions and is expected in the fourth quarter of 2021.

Virus 52

Virus Assay Development Disease Research 52

The Pharma Data

JANUARY 14, 2021

14, 2021 — One month after the United States began what has become a troubled rollout of a national COVID-19 vaccination campaign, the effort is finally gathering real steam. variant that has acquired three more gene mutations not previously seen together in the virus. © 2021 HealthDay. Posted: January 2021.

Vaccine 52

Vaccine Virus Research Disease 52

The Pharma Data

JANUARY 7, 2021

7, 2021 — The American Red Cross is urging COVID-19 survivors to donate blood plasma for hospital patients who need it to recover. People who have recovered from COVID-19 may have antibodies in their plasma that could give a patient’s immune system the boost it needs to beat the virus. © 2021 HealthDay. Professional.

Hospitals 52

Hospitals Virus Production 52

The Pharma Data

JANUARY 6, 2021

6, 2021 — The American Red Cross is urging COVID-19 survivors to donate blood plasma for hospital patients who need it to recover. People who have recovered from COVID-19 may have antibodies in their plasma that could give a patient’s immune system the boost it needs to beat the virus. © 2021 HealthDay.

Hospitals 52

Hospitals Virus Packaging Production 52

The Pharma Data

NOVEMBER 17, 2021

It uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein. Data on File Number: REF-131228, 10 November, 2021. Available at: [link] [Accessed August 2021] 6.

Vaccine 52

Vaccine Clinical Trials Virus Licensing 52

The Pharma Data

JANUARY 8, 2021

8, 2021 — Moderna CEO Stéphane Bancel said the company’s COVID-19 vaccine may prevent infection for years, CBS News reported Thursday. Centers for Disease Control and Prevention says that because reinfection is possible with COVID-19, even people who have already had the virus should still receive the vaccine. Professional.

Vaccine 52

Vaccine Virus Disease 52

The Pharma Data

JANUARY 13, 2021

13, 2021 — The bacteria in your gut may play a role in the severity of COVID-19 infection and the strength of your immune system response, a new study suggests. “Restoration of the missing beneficial bacteria might boost our immunity against SARS-CoV2 virus and hasten recovery from the disease,” she said.

Virus 52

Virus Hospitals Disease Research 52

The Pharma Data

JULY 6, 2021

If a virus is disease-causing, the right mutation can allow the virus to escape the immune response by changing the viral pieces the immune system uses to recognize the virus as a threat, pieces scientists call epitopes. ” You can think of a virus’s structure like the design of a house, explains Nathan. .

Vaccine 52

Vaccine Virus Research Immune Response 52

The Pharma Data

AUGUST 16, 2021

During challenge with the original SARS-CoV-2 virus, animals vaccinated with CV2CoV were found to be better protected based on highly effective clearance of the virus in the lungs and nasal passages. Clearance of the virus in the lungs and nasal passages of the animals was tested following challenge infection with the original virus.

Immune Response 52

Immune Response Vaccine Virus RNA 52

The Pharma Data

JULY 28, 2021

There are many reasons that an intranasal vaccine against the SARS-CoV-2 virus would be helpful in the fight against COVID-19 infections, University of Alabama at Birmingham immunologists Fran Lund, Ph.D., Science 23 Jul 2021. and Troy Randall, Ph.D., write in a viewpoint article in the journal Science. Scent of a vaccine.

Vaccine 52

Vaccine Virus Clinical Trials Science 52

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax’s CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. EMERYVILLE, Calif. and CHENGDU, China , Feb.

Vaccine 52

Vaccine Trials Virus RNA 52

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. Similar to other enveloped RNA viruses such as HIV, RSV and Influenza, SARS-CoV-2 is also an RNA virus that has a trimeric spike (S) protein on its viral envelope.

Clinical Trials 52

Clinical Trials Vaccine Trials Virus 52

The Pharma Data

JANUARY 22, 2021

22, 2021 — An antibody drug that has emergency use authorization from the U.S. Food and Drug Administration for use in early-stage COVID-19 patients with symptoms prevented COVID-19 infections in nursing residents and staff who were exposed to the virus, a new study shows. © 2021 HealthDay. Posted: January 2021.

Nurses 52

Nurses Drugs Virus 52

The Pharma Data

NOVEMBER 23, 2020

It is an mRNA vaccine that codes for the virus’s spike protein and is encapsulated in a lipid nanoparticle. Once injected, the cells churn out the spike protein, triggering the body’s immune system to recognize the virus. Likely EUA Date: Possibly January 2021, but unclear in the U.S. Type: mRNA. Doses: 2, 28 Days Apart.

Vaccine 52

Vaccine Virus Immune Response Trials 52

The Pharma Data

JULY 28, 2021

The analysis included 945,941 mRNA participants (778,534 with two doses), 426,272 Vaxzevria participants, conducted between 27 December 2020 and 19 May 2021. After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.

Vaccine 52

Vaccine Virus Science Disease 52

The Pharma Data

OCTOBER 28, 2020

In the overall patient group with detectable virus at baseline, the average daily reduction in viral load through day 7 was a 0.36 About REGN-COV2 REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19.

Virus 40

Virus Trials Clinical Trials Production 40

FDA Law Blog: Drug Discovery

DECEMBER 7, 2022

In June 2021, uniQure provided another regulatory update , announcing that FDA was requiring a demonstration of “durability of effect” based on data from patients followed for at least 52 weeks after FIX levels achieve steady state, which occurs by 26 weeks.

Therapies 119

Therapies FDA FDA Approval Treatment 119

The Pharma Data

JANUARY 20, 2021

20, 2021 — The Abbott BinaxNOW COVID-19 Ag Card (BinaxNOW) rapid antigen test has lower sensitivity than reverse transcription-polymerase chain reaction (RT-PCR) for detecting severe acute respiratory syndrome coronavirus 2 infection, according to research published in the Jan. © 2021 HealthDay. Posted: January 2021.

Virus 52

Virus Disease Research 52